Gleason Group, Inc.
Source: SEC Form 13F · as of Mar 2026Gleason Group, Inc. holds 17 biotech & pharma companies tracked by BioSniper, totaling $4.5M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$4.5M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 6,425 | $1.6M |
| GILDGILEAD SCIENCES, INC. | 9,273 | $1.3M |
| LLYELI LILLY & Co | 1,343 | $1.2M |
| AMGNAMGEN INC | 367 | $129K |
| MRKMerck & Co., Inc. | 696 | $84K |
| ACTUACTUATE THERAPEUTICS, INC. | 19,028 | $52K |
| RNTXRein Therapeutics, Inc. | 22,389 | $29K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 93 | $25K |
| ABBVAbbVie Inc. | 93 | $20K |
| PMPhilip Morris International Inc | 85 | $14K |
| BMYBRISTOL MYERS SQUIBB CO | 200 | $12K |
| MDXGMiMedx Group Inc | 2,712 | $11K |
| ABTABBOTT LABORATORIES | 91 | $9K |
| INCYIncyte Corp. | 81 | $8K |
| MCKMcKesson Corporation | 7 | $6K |
| PFEPFIZER INC | 197 | $6K |
| VTRSViatris Inc | 24 | $324 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.